Sign In

Lynne Brookes

Chief Operating Officer at Synchrony Group

Lynne Brookes is a seasoned commercial and business development executive with over 25 years of experience in various functional areas like new product planning, business development, marketing, and sales.

She has a proven track record of successfully establishing processes, building departments, and developing personnel from the ground up. Notable achievements include managing the product launches of PROVIGIL, ACTIQ, and FENTORA.

Lynne's expertise lies in market development, product and brand management, product launches and re-launches, new product planning, product valuations and forecasting, business development, and sales planning.

She has held key positions at reputable companies like Galleon, Cephalon, Genentech, and Merck, showcasing her diverse experience in the pharmaceutical and healthcare industries.

With an MBA from the prestigious Wharton School of the University of Pennsylvania and a BS in Chemistry from Yale University, Lynne Brookes combines academic excellence with practical industry knowledge to drive business success.

During her career, Lynne has served in leadership roles such as Chief Operating Officer at Synchrony Group, Chief Business Officer, and Senior Vice President at Galleon Pharmaceuticals, Vice President of Business Development at Cephalon, Vice President of Marketing (CNS/Pain) at Cephalon, Senior Director of Marketing at Cephalon, Senior Associate at Genentech, and Sales Representative at Merck.

Her extensive experience and education make Lynne Brookes a sought-after expert in the areas of commercial strategy, business development, product management, and market expansion within the pharmaceutical and healthcare sectors.

Lynne Brookes
Add to my network

Location

Malvern, Pennsylvania, United States